SHARDACROP - Sharda Cropchem Limited Share Price

Management's outlook expresses strong confidence in continued growth for Sharda Cropchem in FY2027, expecting revenue to increase by 10% to 15%, supported by steady demand in the global agrochemical market. They indicate healthy gross margins should remain around 35%, with EBITDA margins targeted between 18% and 20%.

Key forward-looking points from management include:

1. Revenue Growth: A projected revenue increase of 10% to 15% for FY27, reflecting overall market dynamics and the company's strategic initiatives.

2. Margins: Assurance that gross margins are expected to stay stable around 35%, while EBITDA margins are anticipated to maintain between 18% to 20%.

3. Product Registrations: As of March 31, 2026, the company has completed 3,011 product registrations, with an additional 1,004 applications in the pipeline. Management remains optimistic about receiving new registrations, despite the unpredictability of regulatory timelines.

4. Performance Indicators: For Q4 FY26, total revenue rose by 13% to INR 2,065 crores, while annual revenues reached INR 5,268 crores, marking a 22% year-on-year increase. EBITDA grew 75% to INR 513 crores, with a PAT of INR 319 crores, reflecting a 57% increase.

5. Working Capital: Improvement in working capital days to 98 as of March 31, 2026, down 20 days from the previous year.

6. Dividends: The board recommends a final dividend of INR 9 per share in addition to an interim dividend of INR 6 per share for FY26, totaling INR 15 per share.

These insights position Sharda Cropchem to leverage its strong market presence and overcome industry challenges effectively.

Here are the major questions and their detailed answers from the Q&A section of the earnings transcript:

1. Question by Anubhav Mukherjee: "Can you please share what was the contribution of Forex and realization year-on-year for the current quarter?" Answer by R.V. Bubna: For Q4 FY26, the volume growth was +4.3%. The FOREX impact contributed +11.7%, while the price and product mix had a negative impact of -3.0%. The total growth, thus, was +2.9%.

2. Question by Disha from Sapphire Capital: "What gives us the confidence to maintain high margins in such a volatile environment?" Answer by R.V. Bubna: Our confidence comes from our market feel, regular customer communications, and the stable situation in the agrochemical sector. We also typically pass 80-90% of raw material price hikes to customers due to limited competition.

3. Question by Rajat Setiya from ithought PMS: "What were the gross margins in Europe in this quarter and full year?" Answer by R.V. Bubna: In Q4, Europe's gross margin was 41.5%, and for the full year, it was approximately 42.5%.

4. Question by Vivek Gautam from GS Investment: "Is there a perception that we are being treated like a trading company?" Answer by R.V. Bubna: We market registered products and are not a trading company. Our sales come from regular suppliers, reinforcing our branding as a marketing firm with significant IP.

5. Question by Rohit Nagraj from 360 One Capital: "Have we seen challenges in terms of sourcing material from China?" Answer by R.V. Bubna: There are no sourcing challenges related to the war. While there is uncertainty, supplies remain stable, and recent increases in transport costs have been insignificant for our operations.

6. Question by Madhur Rathi from Counter Cyclical Investments: "Can we assess inventory normalization as restocking or sell-through to the end market?" Answer by R.V. Bubna: Our inventory situation is well-managed and under control. We are in tune with market demands, which helps us navigate both restocking and immediate sales.

7. Question by Anubhav Mukherjee: "Have we benefited from any agrochemical products that have gone off patent recently?" Answer by R.V. Bubna: There have indeed been products that went off-patent, which is a regular market trend, affecting our growth through normal supply-demand dynamics.

8. Question by Rajat Setiya: "What is the expected revenue from new products launched in the last 3 years?" Answer by R.V. Bubna: I estimate that revenue from new products launched over the last 3-4 years could be around 30%.

9. Question by Madhur Rathi: "As regulatory timelines have stretched, how should we view competition and our registration pipeline?" Answer by R.V. Bubna: Competition is limited, but our business is not solely driven by new registrations. We have ample growth potential due to our existing market share and demand for agricultural products.

10. Question by Vedant from Mas Investments: "Is the 10% to 15% growth guidance for FY27 based on volume or price?"

Answer by R.V. Bubna: The 10% to 15% guidance includes both volume and price growth, and it reflects my current impression, which is subject to change based on market conditions.